01.07.2002 | Original Article
Prediction of an HLA-DR-binding peptide derived from Wilms’ tumour 1 protein and demonstration of in vitro immunogenicity of WT1(124–138)-pulsed dendritic cells generated according to an optimised protocol
Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 5/2002
Einloggen, um Zugang zu erhalten